All results
1 results for different strains bcg or without vaccine high grade non muscle invasive bladder
-
Addition of Pembrolizumab to Usual Intravesical Gemcitabine for Treatment of BCG-Unresponsive NMIBC
This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does…
- Ages
- 18 Years - N/A
- Sexes
- All